Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $249,515 | 110 | 80.1% |
| Food and Beverage | $31,655 | 1,085 | 10.2% |
| Consulting Fee | $15,910 | 8 | 5.1% |
| Travel and Lodging | $11,423 | 56 | 3.7% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $2,500 | 1 | 0.8% |
| Entertainment | $620.57 | 17 | 0.2% |
| Education | $55.40 | 8 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $209,011 | 307 | $0 (2024) |
| ABBVIE INC. | $66,307 | 326 | $0 (2024) |
| Merck Sharp & Dohme LLC | $20,787 | 51 | $0 (2024) |
| Shionogi Inc | $3,397 | 5 | $0 (2019) |
| Synergy Pharmaceuticals Inc | $2,890 | 73 | $0 (2018) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $1,902 | 157 | $0 (2024) |
| Romark Laboratories, LC | $1,037 | 41 | $0 (2020) |
| Takeda Pharmaceuticals U.S.A., Inc. | $862.21 | 48 | $0 (2024) |
| Intercept Pharmaceuticals, Inc. | $591.59 | 27 | $0 (2024) |
| Janssen Biotech, Inc. | $573.48 | 38 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $20,180 | 118 | Gilead Sciences, Inc. ($12,790) |
| 2023 | $22,220 | 156 | Gilead Sciences, Inc. ($15,008) |
| 2022 | $19,829 | 139 | Gilead Sciences, Inc. ($18,361) |
| 2021 | $18,662 | 157 | Gilead Sciences, Inc. ($16,930) |
| 2020 | $16,320 | 91 | Gilead Sciences, Inc. ($15,311) |
| 2019 | $64,961 | 172 | Gilead Sciences, Inc. ($39,326) |
| 2018 | $64,406 | 247 | Gilead Sciences, Inc. ($44,302) |
| 2017 | $85,100 | 205 | Gilead Sciences Inc ($46,983) |
All Payment Transactions
1,285 individual payment records from CMS Open Payments — Page 1 of 52
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $4.51 | General |
| Category: IMMUNOLOGY | ||||||
| 12/17/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $28.80 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/16/2024 | ABBVIE INC. | CREON (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $20.00 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/13/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $123.64 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/05/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $24.54 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 12/04/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/02/2024 | ABBVIE INC. | MAVYRET (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,500.00 | General |
| Category: VIROLOGY | ||||||
| 11/27/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $18.50 | General |
| Category: Immunology | ||||||
| 11/25/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/21/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $23.17 | General |
| Category: IMMUNOLOGY | ||||||
| 11/21/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $10.99 | General |
| Category: IMMUNOLOGY | ||||||
| 11/18/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $71.99 | General |
| Category: VIROLOGY | ||||||
| 11/08/2024 | Gilead Sciences, Inc. | Vemlidy (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,030.00 | General |
| Category: HBV | ||||||
| 11/07/2024 | Gilead Sciences, Inc. | Vemlidy (Drug) | Food and Beverage | In-kind items and services | $124.97 | General |
| Category: HBV | ||||||
| 11/07/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $20.13 | General |
| Category: IMMUNOLOGY | ||||||
| 10/31/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $17.43 | General |
| Category: IMMUNOLOGY | ||||||
| 10/28/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $10.18 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/24/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $61.74 | General |
| Category: VIROLOGY | ||||||
| 10/24/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $19.54 | General |
| Category: Immunology | ||||||
| 10/18/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $24.68 | General |
| 10/17/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $20.56 | General |
| Category: GI | ||||||
| 10/16/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $27.49 | General |
| 10/16/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $24.65 | General |
| 10/14/2024 | Takeda Pharmaceuticals U.S.A., Inc. | VPRIV (Biological) | Food and Beverage | In-kind items and services | $32.78 | General |
| Category: GENETIC DISEASE | ||||||
| 10/10/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 104 | 111 | $45,775 | $13,751 |
| 2022 | 4 | 111 | 115 | $47,900 | $14,208 |
| 2021 | 6 | 157 | 163 | $69,775 | $19,059 |
| 2020 | 7 | 168 | 183 | $68,175 | $16,565 |
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 41 | 41 | $10,250 | $5,579 | 54.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 37 | 44 | $8,800 | $4,694 | 53.3% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 15 | 15 | $14,625 | $1,759 | 12.0% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 11 | 11 | $12,100 | $1,718 | 14.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 50 | 50 | $12,500 | $6,409 | 51.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 33 | 37 | $7,400 | $3,728 | 50.4% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 14 | 14 | $14,350 | $2,432 | 17.0% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 14 | 14 | $13,650 | $1,639 | 12.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 51 | 51 | $12,750 | $6,919 | 54.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 42 | 48 | $9,600 | $5,082 | 52.9% |
| 45378 | Diagnostic examination of the colon (large bowel) using an endoscope(colonoscopy); high risk | Facility | 2021 | 13 | 13 | $13,325 | $2,407 | 18.1% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 15 | 15 | $16,500 | $2,274 | 13.8% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 16 | 16 | $15,600 | $1,853 | 11.9% |
| 99211 | Established patient outpatient visit, minimal presenting problem | Office | 2021 | 20 | 20 | $2,000 | $523.83 | 26.2% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 33 | 33 | $8,250 | $4,108 | 49.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 36 | 48 | $9,600 | $4,102 | 42.7% |
| 45380 | Biopsy of large bowel using an endoscope | Facility | 2020 | 20 | 20 | $22,000 | $2,679 | 12.2% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2020 | 19 | 19 | $18,525 | $2,281 | 12.3% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 15 | 15 | $3,375 | $1,300 | 38.5% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 12 | 13 | $2,925 | $1,123 | 38.4% |
| 99211 | Established patient office or other outpatient visit, typically 5 minutes | Office | 2020 | 33 | 35 | $3,500 | $973.35 | 27.8% |
About Dr. David Stein, MD
Dr. David Stein, MD is a Gastroenterology healthcare provider based in Bronx, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/26/2005. The National Provider Identifier (NPI) number assigned to this provider is 1285620237.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Stein, MD has received a total of $311,679 in payments from pharmaceutical and medical device companies, with $20,180 received in 2024. These payments were reported across 1,285 transactions from 48 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($249,515).
As a Medicare-enrolled provider, Stein has provided services to 540 Medicare beneficiaries, totaling 572 services with total Medicare billing of $63,582. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location Bronx, NY
- Active Since 09/26/2005
- Last Updated 07/22/2010
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1285620237
Products in Payments
- Epclusa (Drug) $70,842
- Vemlidy (Drug) $63,514
- Mavyret (Drug) $41,237
- ZEPATIER (Drug) $20,490
- MAVYRET (Drug) $10,863
- Viekira (Drug) $10,757
- Vosevi (Drug) $5,053
- Mulpleta (Drug) $3,397
- Trulance (Drug) $2,890
- XIFAXAN (Drug) $1,855
- RINVOQ (Biological) $998.05
- Alinia Tablets 500mg 30 count bottle (Drug) $763.46
- STELARA (Biological) $698.44
- HUMIRA (Biological) $695.46
- SKYRIZI (Biological) $661.49
- Humira (Biological) $602.08
- ZEPOSIA (Drug) $543.26
- OCALIVA (Drug) $540.66
- ENTYVIO (Biological) $464.68
- LINZESS (Drug) $380.12
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Bronx
Dr. Sammy Ho, Md, MD
Gastroenterology — Payments: $215,849
Dr. Nithan Narendra, M.d, M.D
Gastroenterology — Payments: $170,185
Dr. Andrea Culliford, Md, MD
Gastroenterology — Payments: $156,831
Dr. Hatef Massoumi, M.d, M.D
Gastroenterology — Payments: $68,250
Robert Sable, M.d, M.D
Gastroenterology — Payments: $43,693
Lawrence Brandt, Md, MD
Gastroenterology — Payments: $20,775